Franck Molin

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Usefulness of Fluorine-18 Positron Emission Tomography/Computed Tomography for Identification of Cardiovascular Implantable Electronic Device Infections

J. Sarrazin, François Philippon, Michel Tessier et al. · Journal of the American College of Cardiology · 2012 · 280 citations

Medical Electronics, Engineering, Health Sciences +10

Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial

Michael R. Gold, Pier D. Lambiase, Mikhael F. El‐Chami et al. · Circulation · 2020 · 211 citations · Full text

Reduced Incidence of Vagally Induced Atrial Fibrillation and Expression Levels of Connexins by n-3 Polyunsaturated Fatty Acids in Dogs

J. Sarrazin, Geneviève Comeau, Pascal Daleau et al. · Journal of the American College of Cardiology · 2007 · 106 citations

Expression Levels, Omega-3 Fatty Acid, Medicine +5

A Novel Wearable Device for Continuous Ambulatory ECG Recording: Proof of Concept and Assessment of Signal Quality

Christian Steinberg, François Philippon, Marina Sánchez et al. · Biosensors · 2019 · 105 citations · Full text